Daily-diary evaluated side effects of dose-escalation radiotherapy of prostate cancer using the stereotactic BeamCath® technique

Acta Oncologica

Volumn 42, Issue 4, 2003, Pages 326-333

  Fransson, Per ^a   Bergström, Per ^a   Löfroth, Per Olov ^a   Franzén, Lars ^a   Henriksson, Roger ^a   Widmark, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROENTEROLOGY; PATIENT TREATMENT; RADIOTHERAPY; TOXICITY; TUMORS;

DOSE ESCALATION;

ONCOLOGY;

ACCURACY; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; DOSE RESPONSE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; SELF EVALUATION; URINARY FREQUENCY; URINARY URGENCY; URINE CATHETER;

DIARRHEA; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; INTESTINES; MALE; MEDICAL RECORDS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME; URINARY TRACT; URINATION DISORDERS;

EID: 0037488308     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310004346     Document Type: Article

References (19)

1. Pollack A, Zagars GK, Starkschall G, et al. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys 1996; 34: 555-64.
2. Widmark A, Fransson P, Franzen L, Littbrand B, Henriksson R. Daily-diary evaluated side effects of conformal versus conventional prostatic cancer radiotherapy technique. Acta Oncol 1997; 36: 499-507.
3. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radio-therapy in prostate cancer: a randomised trial [see comments]. Lancet 1999; 353: 267-72.
4. Sandler HM, McLaughlin PW, Ten Haken RK, Addison H, Forman J, Lichter A. Three dimensional conformal radio-therapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. Int J Radiat Oncol Biol Phys 1995; 33: 797-801.
5. Roach III M, Pickett B, Weil M, Verhey L. The 'critical volume tolerance method' for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1996; 35: 1019-25.
6. Pollack A, Zagars GK. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 39: 1011-8.
7. Hanks GE, Hanlon AL, Schultheiss TE, Pinover WH, Movsas B, Epstein BE, et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998; 41: 501-10.
8. Zelefsky MJ, Leibel SA, Kutcher GJ, Fuks Z. Three-dimensional conformal radiotherapy and dose escalation: where do we stand? Semin Radiat Oncol 1998; 8: 107-14.
9. Pollack A, Zagars GK, Smith LG, et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 G with 78 Gy for prostate cancer. J Clin Oncol 2000; 18: 3904-11.
10. Sandler HM, Perez Tamayo C, Ten Haken RK, Lichter AS. Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol 1992; 23: 53-4.
11. Lee WR, Hanks GE, Hanlon AL, Schultheiss TE, Hunt MA. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect [see comments]. Int J Radiat Oncol Biol Phys 1996; 35: 251-7.
12. Bergström P, Löfroth P-O, Widmark A. High-precision conformal radiotherapy (HPCRT) of prostate cancer - a new technique for exact positioning of the prostate at the time of treatment. Int J Radiat Oncol Biol Phys 1998; 42: 305-11.
13. Fransson P, Löfroth P-O, Franzén L, Henriksson R, Bergström P, Widmark A. Acute side effects after dose-escalation treatment of prostate cancer using the new urethral catheter BeamCath technique. Acta Oncol 2001; 40: 756-65.
14. Henriksson R, Franzén L, Littbrand B. Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. J Clin Oncol 1992; 10: 969-75.
15. Landberg T, Chavaudra J, Dobbs J, et al. ICRU REPORT 50. Prescribing, recording and reporting photon beam therapy. Int Comm Radiat Units Measure 1993.
16. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer [see comments]. Int J Radiat Oncol Biol Phys 1998; 41: 491-500.
17. Boersma LJ, van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998; 41: 83-92.
18. Roach III M. Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities [letter]. Radiother Oncol 1996; 40: 85-7.
19. Zelefsky MJ, Harrison A. Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy. Urology 1997; (Suppl): 38-45.